SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Centers for Disease Control. Diffuse undifferentiated non-Hodgkin's lymphoma among homosexual males: United States. MMWR Morb Mortal Wkly Rep 1982;31: 277.
  • 2
    Levine AM, Meyer PR, Begandy MK, et al. Development of B-cell lymphoma in homosexual men. Ann Intern Med 1984; 100: 713.
  • 3
    Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984; 311(9): 565570.
  • 4
    Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. Ann Intern Med 1985;103: 402403.
  • 5
    Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000; 27(4): 390401.
  • 6
    Cote TR, Biggar RF, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation, and public health burden. Int J Cancer 1997; 73: 645650.
  • 7
    Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996; 10(5): 9971010.
  • 8
    Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkins lymphoma. Lancet 1991; 337: 805809.
  • 9
    Peters BS, Beck EK, Coleman DG, et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ 1991; 302: 203207.
  • 10
    International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92(22): 18231830.
  • 11
    Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ 1999; 319: 2324.
  • 12
    Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 2000; 96: 27302734.
  • 13
    Cesarman E, Chang Y, Moore PS, Said JW, Knowles D. Kaposi's sarcoma-associated herpesvirus-like DNA sequence are present in AIDS-related body cavity based lymphomas. N Engl J Med 1995; 332: 11861191.
  • 14
    Levine AM. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol 2000; 27(4): 442453.
  • 15
    Lowenthal DA, Straus DJ, Campbell SW, Gold JWM, Clarkson BD, Kozinger B. AIDS-related lymphoid neoplasia: the Memorial hospital experience. Cancer 1988; 61: 23252537.
  • 16
    Rodriguez-Sanjuan JC, Echevarria S, Alvarez-Canas C. Primary gastric lymphoma in an HIV-infected patient. J Acquir Immune Defic Syndr Human Retrovirol 1996; 13(5): 467468.
  • 17
    Wotherspoon AC, Diss TC, Singh N, Whelan J, Isaacson PG. Low-grade B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients. Histopathology 1996; 28(2): 129134.
  • 18
    Chetty R, Pillay SV. Coexistent gastric MALT lymphoma and Kaposi's sarcoma in an HIV positive patient. J Clin Pathol 1999; 52(4): 313316.
  • 19
    Teruya-Feldstein J, Temeck BK, Sloas MM, et al. Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient Am J Surg Pathol 1995;19(3): 357363.
  • 20
    Sundaram K, Singh B, Har-El G. Nasopharyngeal mucosa-associated lymphoid tissue lymphoma in patients infected with human immunodeficiency virus. Am J Otolaryngol 1999; 20(1): 5658.
  • 21
    Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 1983; 78: 427434.
  • 22
    SAS/STAT users guide. Version 8. Cary NC: SAS Institute, 1999: 25052552.
  • 23
    Kalbfliesch JD, Prentice RI. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
  • 24
    Tarone RE, Ware J. On distribution-free tests for equality of survival distributions. Biometrika 1997; 6: 156.
  • 25
    Levine AM, Gill PS, Cohen J, et al. Suramin anti-viral therapy in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 3237.
  • 26
    Levine AM, Seneviratne L, Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood 2000; 96: 40844090.
  • 27
    Levine AM, Wernz JC, Kaplan L, et al. Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. JAMA 1991; 226: 8488.
  • 28
    Kaplan LD, Straus DJ, Testa MA, et al. Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 1997; 336: 16411648.
  • 29
    The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 1997;89(11): 39093918.
  • 30
    Armitage JO, Weisenburger DD. New approach to classifying Non-Hodgkin's lymphoma: clinical features of the major histologic subtypes. J Clin Oncol 1998; 16(8): 27802795.
  • 31
    The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49: 21122135.
  • 32
    Pluda JM, Venzon DJ, Tossato G, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993; 11: 10991007.
  • 33
    Centers for Disease Control. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV infected patients surviving for prolonged periods on anti-retroviral therapy: United States. MMWR Morb Mortal Wkly Rep 1991;40: 597600.
  • 34
    Palella FJ Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human deficiency infection: HIV Outpatient Study Investigators. N Engl J Med 1996;335: 10811090.
  • 35
    Grulich AE. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. J Acquir Immune Def Syndr Hum Retrovirol 1999; 21: s27s30.